Explore

TrendlineTrendline
Super Age Games Tests Longevity Markers in Fitness Competition

Super Age Games Tests Longevity Markers in Fitness Competition

Super Age Games Tests Longevity Markers in Fitness Competition
TrendlineTrendline
MedStar Health Emphasizes Holistic Approach to Healthy Aging Beyond Diet and Exercise

MedStar Health Emphasizes Holistic Approach to Healthy Aging Beyond Diet and Exercise

MedStar Health Emphasizes Holistic Approach to Healthy Aging Beyond Diet and Exercise
TrendlineTrendline
USC Professor Discusses Combined Dietary Approaches for Longevity and Disease Prevention

USC Professor Discusses Combined Dietary Approaches for Longevity and Disease Prevention

USC Professor Discusses Combined Dietary Approaches for Longevity and Disease Prevention
Rapid ReadRapid Read
GLP-1 Medications Show Promise in Influencing Epigenetic Aging Markers and Extending Lifespan in Mice

GLP-1 Medications Show Promise in Influencing Epigenetic Aging Markers and Extending Lifespan in Mice

Recent research presented at the 2026 Aging Research and Drug Discovery Meeting indicates that GLP-1 medications, such as semaglutide and tirzepatide, are positively influencing epigenetic aging clocks. Novo Nordisk reported that semaglutide improved biological aging measures across multiple organ systems, including the heart and kidneys. Similarly, Eli Lilly presented findings that tirzepatide, found in prescriptions like Mounjaro and Zepbound, affected several epigenetic aging clocks, including organ-specific markers for the heart, kidney, liver, and immune system. A study published in Nature also found that semaglutide extended the lifespan of older female mice by approximately 12 percent, alongside improvements in physical and cognitive function. These independent observations suggest that GLP-1-based therapies may impact biological aging through various molecular pathways, extending these molecular observations to actual lifespan and demonstrating improvements in several hallmarks of aging.
Rapid ReadRapid Read
Reps. Carson and Wittman Introduce Bipartisan Bill for National Young Adult Cancer Strategy

Reps. Carson and Wittman Introduce Bipartisan Bill for National Young Adult Cancer Strategy

Reps. André Carson (D-Ind.) and Rob Wittman (R-Va.) have introduced bipartisan legislation in the U.S. House of Representatives to establish the Asal Sayas National Strategy on Young Adult Cancers Act. This bill aims to create the first national strategy specifically addressing cancers in adults aged 18 to 49. The Colorectal Cancer Alliance is leading a national effort to gather support for this bill, encouraging patients, caregivers, advocates, and organizations to sign up and help ensure its passage. The proposed legislation would mandate the National Institutes of Health (NIH) to develop a comprehensive strategy within 18 months of the bill becoming law. This strategy would involve mapping current research, launching a national education campaign to raise awareness of symptoms and risk factors, setting research priorities for causes, biomarkers, early detection, and new treatments, and reducing barriers to clinical trial participation for young adults. Companion legislation was previously introduced in ...
TrendlineTrendline
Bodyweight Training Offers Accessible Muscle Building and Cardiovascular Benefits

Bodyweight Training Offers Accessible Muscle Building and Cardiovascular Benefits

Bodyweight Training Offers Accessible Muscle Building and Cardiovascular Benefits
Rapid ReadRapid Read
African Institutions Urged to Lead Antimicrobial Resistance Research, Shape Next-Gen Antibiotics and Diagnostics

African Institutions Urged to Lead Antimicrobial Resistance Research, Shape Next-Gen Antibiotics and Diagnostics

African institutions are called upon to play a leading role in antimicrobial resistance (AMR) research, influencing the development and testing of next-generation antibiotics and diagnostics. The World Health Organization's 2025 assessments highlighted ongoing gaps in antibacterial innovation, pediatric formulations, and oral treatments, as well as limited simple diagnostic tools for primary and secondary care. The article emphasizes that surveillance data, such as that from Kenya and Rwanda's expanded Global Antimicrobial Resistance and Use Surveillance System (GLASS), should inform target product profiles for new medical tools. It advocates for African institutions to help define research questions, select meaningful outcomes, and interpret site-specific differences, ensuring that new products are designed for the conditions in which they will be used.
Rapid ReadRapid Read
Low-Income Seniors Reduce Prescription Spending Due to Cost Sharing, Regardless of Medical Benefit

Low-Income Seniors Reduce Prescription Spending Due to Cost Sharing, Regardless of Medical Benefit

A study published in the November 2026 issue of the American Economic Journal: Economic Policy, authored by economist Christopher Hollrah, reveals that low-income seniors significantly reduce their prescription spending when faced with higher out-of-pocket costs, irrespective of the medical benefit of the drugs. Hollrah examined Medicare's Low-Income Subsidy, which typically limits copays to a few dollars. By comparing similar patients who either retained or lost this subsidy due to Medicaid eligibility timing rules, the study found that losing the subsidy led to a 40 percent reduction in prescription spending and a 16 percent decrease in the quantity of prescriptions filled. The analysis showed that patients economized on higher-priced drugs, with 60 percent of the spending reduction coming from high-benefit prescriptions, compared to 15 percent from lower-benefit ones. For example, insulin purchases, which cost approximately $70 per fill without the subsidy, dropped by 35 percent. The study concluded tha...
TrendlineTrendline
Lifestyle Factors Significantly Impact Longevity, According to Women's Health Initiative Study

Lifestyle Factors Significantly Impact Longevity, According to Women's Health Initiative Study

Lifestyle Factors Significantly Impact Longevity, According to Women's Health Initiative Study
TrendlineTrendline
Longevity as a Lifestyle: Bridging the Gap Between Interest and Action in Healthy Aging

Longevity as a Lifestyle: Bridging the Gap Between Interest and Action in Healthy Aging

Longevity as a Lifestyle: Bridging the Gap Between Interest and Action in Healthy Aging
TrendlineTrendline
Wellness Author Daniel Wei Chen Advocates for Accessible Movement and Mobility

Wellness Author Daniel Wei Chen Advocates for Accessible Movement and Mobility

Wellness Author Daniel Wei Chen Advocates for Accessible Movement and Mobility
Rapid ReadRapid Read
Intensive Lifestyle Intervention Benefits Brain Microstructure in Younger Older Adults

Intensive Lifestyle Intervention Benefits Brain Microstructure in Younger Older Adults

A secondary analysis of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (US POINTER) has revealed that intensive lifestyle interventions can significantly benefit brain microstructure in older adults, particularly those under 70 years old. The study, published in JAMA Network Open, investigated how diffusion magnetic resonance imaging (MRI)-derived free water (FW), an early biomarker of white matter injury, responds to structured lifestyle interventions. Participants aged 60 to 79 years underwent MRI scans at baseline and over 24 months. The structured intervention, which included supervised exercise, dietary counseling, cognitive and social engagement, and health coaching, was found to attenuate increases in global white matter FW in participants younger than 70 years. This effect was not observed in participants aged 70 and older. The researchers suggest that FW is an early, intervention-responsive marker of cerebrovascular brain health, indicating that earlier implem...